Found: 60
Select item for more details and to access through your institution.
Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 7, p. 459, doi. 10.1016/j.clml.2024.03.001
- By:
- Publication type:
- Article
SHP2 inhibition displays efficacy as a monotherapy and in combination with JAK2 inhibition in preclinical models of myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 6, p. 1040, doi. 10.1002/ajh.27282
- By:
- Publication type:
- Article
Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 6, p. 1941, doi. 10.1007/s00277-024-05760-6
- By:
- Publication type:
- Article
Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 6, p. 400, doi. 10.1016/j.clml.2024.02.005
- By:
- Publication type:
- Article
Clinical and Therapeutic Intervention of Hypereosinophilia in the Era of Molecular Diagnosis.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1383, doi. 10.3390/cancers16071383
- By:
- Publication type:
- Article
Young patients with myelofibrosis have distinct clinicomolecular features, favorable prognosis, and commonly exhibit inflammatory comorbidities.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 1, p. 117, doi. 10.1007/s00277-023-05564-0
- By:
- Publication type:
- Article
Drivers of deep molecular response and long‐term outcomes in patients with core binding factor acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 12, p. E360, doi. 10.1002/ajh.27092
- By:
- Publication type:
- Article
IDH1/2 inhibitor monotherapy in blast‐phase myeloproliferative neoplasms: A multicentre experience.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 3, p. e87, doi. 10.1111/bjh.19027
- By:
- Publication type:
- Article
Utilization of Serial Next-Generation Sequencing Among Patients Receiving CPX-351 for Newly Diagnosed Acute Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. e315, doi. 10.1016/j.clml.2023.07.002
- By:
- Publication type:
- Article
Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 9, p. 674, doi. 10.1016/j.clml.2023.05.002
- By:
- Publication type:
- Article
Incidence of blast phase in myelofibrosis according to anemia severity.
- Published in:
- EJHaem, 2023, v. 4, n. 3, p. 679, doi. 10.1002/jha2.745
- By:
- Publication type:
- Article
Correction to: Treatment of hydroxyurea-resistant/intolerant polycythemia vera: a discussion of best practices.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 7, p. 1967, doi. 10.1007/s00277-023-05235-0
- By:
- Publication type:
- Article
Treatment of hydroxyurea-resistant/intolerant polycythemia vera: a discussion of best practices.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 5, p. 985, doi. 10.1007/s00277-023-05172-y
- By:
- Publication type:
- Article
Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 5, p. 355, doi. 10.1016/j.clml.2023.01.007
- By:
- Publication type:
- Article
Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors among Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusion.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 3, p. e150, doi. 10.1016/j.clml.2022.12.008
- By:
- Publication type:
- Article
Assessing the role of venetoclax in combination with hypomethylating agents in higher risk myelodysplastic syndrome.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00744-z
- By:
- Publication type:
- Article
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 21, p. 3880, doi. 10.1002/cncr.34459
- By:
- Publication type:
- Article
MOMENTUM: Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) in Symptomatic and Anemic Myelofibrosis (MF) Patients Previously Treated with a JAK Inhibitor.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 11, p. 377
- By:
- Publication type:
- Article
Thrombocytopenic Myelofibrosis (MF) Patients Previously Treated with a JAK Inhibitor in a Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) (MOMENTUM).
- Published in:
- Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 11, p. 388
- By:
- Publication type:
- Article
Disease-related thrombocytopenia in myelofibrosis is defined by distinct genetic etiologies and is associated with unique prognostic correlates.
- Published in:
- 2022
- By:
- Publication type:
- journal article
CPX-351 Yields Similar Response and Survival Outcome in Younger and Older Patients With Secondary Acute Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 10, p. 774, doi. 10.1016/j.clml.2022.06.001
- By:
- Publication type:
- Article
Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy‐related myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 4, p. 713, doi. 10.1111/bjh.18319
- By:
- Publication type:
- Article
Comparison of Different Treatment Strategies for Blast-Phase Myeloproliferative Neoplasms.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. e521, doi. 10.1016/j.clml.2022.01.015
- By:
- Publication type:
- Article
Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia: Is the combination indeed better?
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 5, p. E185, doi. 10.1002/ajh.26504
- By:
- Publication type:
- Article
Multicenter evaluation of efficacy and toxicity of venetoclax‐based combinations in patients with accelerated and blast phase myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 1, p. E7, doi. 10.1002/ajh.26381
- By:
- Publication type:
- Article
Favorable overall survival with imetelstat in relapsed/refractory myelofibrosis patients compared with real-world data.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 139, doi. 10.1007/s00277-021-04683-w
- By:
- Publication type:
- Article
JAK2 inhibitor persistence in MPN: uncovering a central role of ERK activation.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00609-5
- By:
- Publication type:
- Article
Oral Abstract: MDS-229: Assessment of Baseline Clinical and Molecular Characteristics in Indolent Chronic Myelomonocytic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S201, doi. 10.1016/S2152-2650(21)01269-6
- By:
- Publication type:
- Article
Poster: AML-170: High MYC Expression Predicts Poor Survival Outcomes in IDH1/2 Mutant AML Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S212, doi. 10.1016/S2152-2650(21)01331-8
- By:
- Publication type:
- Article
Poster: AML-407: Mutations Highly Specific for Secondary AML are Associated with Poor Outcomes Even in Patients with NPM1 Mutated ELN Favorable Risk AML.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S214, doi. 10.1016/S2152-2650(21)01345-8
- By:
- Publication type:
- Article
Poster: MDS-128: Azacitidine and Venetoclax Combination for Upfront Treatment of Higher-Risk Myelodysplastic Syndromes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S226, doi. 10.1016/S2152-2650(21)01428-2
- By:
- Publication type:
- Article
Poster: MDS-229: Assessment of Baseline Clinical and Molecular Characteristics in Indolent Chronic Myelomonocytic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S227, doi. 10.1016/S2152-2650(21)01433-6
- By:
- Publication type:
- Article
Poster: MPN-244: Comorbid Conditions Occur Frequently and Correlate with Early Disease Progression and Poor Outcomes in Young Patients with Myelofibrosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S232, doi. 10.1016/S2152-2650(21)01460-9
- By:
- Publication type:
- Article
Poster: MPN-236: Different Treatment Approaches to Blast-Phase Myeloproliferative Neoplasms.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S232, doi. 10.1016/S2152-2650(21)01459-2
- By:
- Publication type:
- Article
AML-170: High MYC Expression Predicts Poor Survival Outcomes in IDH1/2 Mutant AML Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S286, doi. 10.1016/S2152-2650(21)01686-4
- By:
- Publication type:
- Article
AML-407: Mutations Highly Specific for Secondary AML are Associated with Poor Outcomes Even in Patients with NPM1 Mutated ELN Favorable Risk AML.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S309, doi. 10.1016/S2152-2650(21)01733-X
- By:
- Publication type:
- Article
MDS-128: Azacitidine and Venetoclax Combination for Upfront Treatment of Higher-Risk Myelodysplastic Syndromes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S341, doi. 10.1016/S2152-2650(21)01794-8
- By:
- Publication type:
- Article
MDS-229: Assessment of Baseline Clinical and Molecular Characteristics in Indolent Chronic Myelomonocytic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S344, doi. 10.1016/S2152-2650(21)01801-2
- By:
- Publication type:
- Article
MPN-244: Comorbid Conditions Occur Frequently and Correlate with Early Disease Progression and Poor Outcomes in Young Patients with Myelofibrosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S358, doi. 10.1016/S2152-2650(21)01826-7
- By:
- Publication type:
- Article
MPN-236: Different Treatment Approaches to Blast-Phase Myeloproliferative Neoplasms.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S358, doi. 10.1016/S2152-2650(21)01825-5
- By:
- Publication type:
- Article
Evaluating Predictors of Immune-Related Adverse Events and Response to Checkpoint Inhibitors in Myeloid Malignancies.
- Published in:
- 2021
- By:
- Publication type:
- letter
Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Retrospective Analysis of the Clinical Use and Benefit of Lenalidomide and Thalidomide in Myelofibrosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Finding a Jill for JAK: Assessing Past, Present, and Future JAK Inhibitor Combination Approaches in Myelofibrosis.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2278, doi. 10.3390/cancers12082278
- By:
- Publication type:
- Article
Defining Acute Myeloid Leukemia Ontogeny in Older Patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Driver mutation‐specific clinical and genomic correlates differ between primary and secondary myelofibrosis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 12, p. E314, doi. 10.1002/ajh.25625
- By:
- Publication type:
- Article
Treatment of MDS/MPN and the MDS/MPN IWG International Trial: ABNL MARRO.
- Published in:
- Current Hematologic Malignancy Reports, 2019, v. 14, n. 6, p. 543, doi. 10.1007/s11899-019-00553-5
- By:
- Publication type:
- Article
Impact of the Number of Consolidation Chemotherapy Cycles Prior to Allogeneic Stem Cell Transplant for Adults with Acute Myeloid Leukemia in First Remission.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S222, doi. 10.1016/j.clml.2019.07.098
- By:
- Publication type:
- Article
Venetoclax Combination with Hypomethylating Agents for Treatment of Myelodysplastic Syndromes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S339, doi. 10.1016/j.clml.2019.07.340
- By:
- Publication type:
- Article
Hypoplastic MDS in the Elderly: A Single Institutional Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S341, doi. 10.1016/j.clml.2019.07.344
- By:
- Publication type:
- Article